Последние исследования

EudraCT Number: 2004-002197-34

Sponsor Protocol Number: 04/Q1104/27

Start Date: 2004-12-14

Sponsor Name: University College London

Full Title: A phase III multicentre randomised clinical trial comparing rituximab with CHOP given every 14 days and rituximab with CHOP given every 21 days for the treatment of patients with newly diagnosed d...

Medical condition: Newly diagnosed diffuse large B cell non-Hodgkin's lymphoma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-002701-68

Sponsor Protocol Number: PSN9301CS01

Start Date: 2004-12-13

Sponsor Name: Prosidion Ltd.

Full Title: A randomised, double-blind, placebo-controlled, multiple dose, time-lagged parallel groups trial, investigating the pharmacodynamics, the safety and tolerability and the pharmacokinetics of PSN9301...

Medical condition: Diabetes mellitus type 2

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003764-30

Sponsor Protocol Number: D/P2/04/3

Start Date: 2004-12-13

Sponsor Name: Diamyd Therapeutics AB

Full Title: A Phase II, Randomised, Double-Blind, Placebo-controlled, Multi-centre Study to Investigate the Impact of Diamyd on the Progression of diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mell...

Medical condition: Type 1 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10045228	Type I diabetes mellitus	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004083-77

Sponsor Protocol Number: NO 002 CS 001

Start Date: 2004-12-13

Sponsor Name: Disphar International B.V.

Full Title: A Randomised, International, Multicenter Study to assess the Efficacy and Safety of Mesalazine EC tablets 500 mg (4.5g/daily) and Salofalk® tablets 500 mg (4.5 g/daily) in the Treatment of Moderate...

Medical condition: Moderate active Crohn disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) SK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000623-16

Sponsor Protocol Number: 1100.1454

Start Date: 2004-12-13

Sponsor Name: Boehringer Ingelheim Ltd

Full Title: A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients

Medical condition: Treatment of HIV-1 infection

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-002276-42

Sponsor Protocol Number: 61/O4/OX/Rh

Start Date: 2004-12-13

Sponsor Name: IVAX Pharmaceuticals s.r.o.

Full Title: Tolerability and safety of Oxamet® in patients with acute rhinitis

Medical condition: Acute rhinitis.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003238-32

Sponsor Protocol Number: v1

Start Date: 2004-12-13

Sponsor Name: Dept. of Clinical Pharmacology

Full Title: Effect of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis

Medical condition: Cirrhosis of the liver

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001989-41

Sponsor Protocol Number: 26866138-MMY-3002

Start Date: 2004-12-13

Sponsor Name: Janssen-Cilag Kft.

Full Title: An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone versus Melphalan/Prednisone in subjects with previously untreated Multiple Myeloma.

Medical condition: First-Line Multiple Myeloma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) FI (Completed) AT (Completed) CZ (Completed) IE (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Ongoing) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002985-39

Sponsor Protocol Number: ML18253

Start Date: 2004-12-13

Sponsor Name: ROCHE

Full Title: A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in...

Medical condition: Treatment of chronic hepatitis B, HBeAg-negative

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10021881 - Infections and infestations	10019731	Hepatitis B	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001953-27

Sponsor Protocol Number: 9321

Start Date: 2004-12-13

Sponsor Name: University Hospitals of Leicester NHS Trust

Full Title: The Pharmacokinetics of Systemic Corticosteriods in Refractory Asthma

Medical condition: Severe, refractory asthma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

Последние исследования

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства